Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
SM Hayter, MC Cook - Autoimmunity reviews, 2012 - Elsevier
Autoimmune diseases are heterogeneous with regard to prevalence, manifestations, and
pathogenesis. The classification of autoimmune diseases has varied over time. Here, we …
pathogenesis. The classification of autoimmune diseases has varied over time. Here, we …
Th17 cells in human disease
LA Tesmer, SK Lundy, S Sarkar… - Immunological reviews, 2008 - Wiley Online Library
Our understanding of the role of T cells in human disease is undergoing revision as a result
of the discovery of T‐helper 17 (Th17) cells, a unique CD4+ T‐cell subset characterized by …
of the discovery of T‐helper 17 (Th17) cells, a unique CD4+ T‐cell subset characterized by …
Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment
L Du, A Kijlstra, P Yang - Progress in retinal and eye research, 2016 - Elsevier
Abstract Vogt-Koyanagi-Harada (VKH) disease is one of the major vision-threatening
diseases in certain populations, such as Asians, native Americans, Hispanics and Middle …
diseases in certain populations, such as Asians, native Americans, Hispanics and Middle …
[HTML][HTML] Autoimmunity, autoinflammation, and infection in uveitis
JV Forrester, L Kuffova, AD Dick - American journal of ophthalmology, 2018 - Elsevier
Purpose To review the pathogenesis of uveitis in light of recent advances in our
understanding of innate and adaptive immune responses and their regulation. Design …
understanding of innate and adaptive immune responses and their regulation. Design …
Vogt–koyanagi–harada syndrome
Objectives The objectives of this study are to review our current knowledge of the
aetiopathogenesis of Vogt–Koyanagi–Harada syndrome, including viral infection, genetic …
aetiopathogenesis of Vogt–Koyanagi–Harada syndrome, including viral infection, genetic …
Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease
T Kawaguchi, S Horie, N Bouchenaki… - International …, 2010 - Springer
Purpose To evaluate clinical and angiographic differences in patients with Vogt-Koyanagi-
Harada (VKH) disease during the early 4-month treatment phase with high-or medium-dose …
Harada (VKH) disease during the early 4-month treatment phase with high-or medium-dose …
Optical coherence tomography diagnostic signs in posterior uveitis
A diagnostic sign refers to a quantifiable biological parameter that is measured and
evaluated as an indicator of normal biological, pathogenic, or pharmacologic responses to a …
evaluated as an indicator of normal biological, pathogenic, or pharmacologic responses to a …
Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: A Systematic Review and Meta-analysis
T Shi, W Lv, L Zhang, J Chen, H Chen - Scientific Reports, 2014 - nature.com
Human leukocyte antigen (HLA)-DR4/HLA-DRB1* 04 has been reported to be a risk factor
for Vogt-Koyanagi-Harada disease (VKH) with various strength of association. Its sub-alleles …
for Vogt-Koyanagi-Harada disease (VKH) with various strength of association. Its sub-alleles …